Immune thrombocytopenia — VA Rating Criteria (38 CFR DC 7705)
The VA rates Immune thrombocytopenia under 38 CFR 38 CFR § 4.117, Diagnostic Code 7705, from 0% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment. Related conditions in the Hematologic body system share this rating framework.
What are the VA rating criteria for Immune thrombocytopenia?
Platelet count above 50,000 and asymptomatic; or for immune thrombocytopenia in remission
Platelet count higher than 30,000 but not higher than 50,000, not requiring treatment
Platelet count higher than 30,000 but not higher than 50,000, with either immune thrombocytopenia or mild mucous membrane bleeding which requires oral corticosteroid therapy or intravenous immune globulin
Requiring immunosuppressive therapy; or for a platelet count higher than 30,000 but not higher than 50,000, with history of hospitalization because of severe bleeding requiring intravenous immune globulin, high-dose parenteral corticosteroids, and platelet transfusions
Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment
“Platelet count higher than 30,000 but not higher than 50,000, with either immune thrombocytopenia or mild mucous membrane bleeding which requires oral corticosteroid therapy or intravenous immune globulin”
How does the VA rate Hematologic conditions?
Common Questions About Immune thrombocytopenia VA Ratings
What is the VA disability rating for Immune thrombocytopenia?
The VA rates Immune thrombocytopenia under Diagnostic Code 7705 at the following tiers: 0%, 10%, 30%, 70%, 100%. The minimum 0% rating requires: Platelet count above 50,000 and asymptomatic; or for immune thrombocytopenia in remission. The maximum 100% rating requires: Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment.
What is Diagnostic Code 7705?
Diagnostic Code 7705 is the VA rating identifier for Immune thrombocytopenia within 38 CFR 38 CFR § 4.117. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.
What is the highest rating for Immune thrombocytopenia?
The highest schedular rating for Immune thrombocytopenia under DC 7705 is 100%. This tier requires: Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment. Veterans who cannot secure substantially gainful employment due to Immune thrombocytopenia alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.
What 38 CFR section governs Immune thrombocytopenia ratings?
Immune thrombocytopenia is rated under 38 CFR 38 CFR § 4.117, Diagnostic Code 7705. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.
Which conditions are commonly secondary to Immune thrombocytopenia?
Secondary conditions caused or aggravated by Immune thrombocytopenia may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.
What evidence do I need to establish service connection for Immune thrombocytopenia?
Service connection for Immune thrombocytopenia requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits